Time-dependent removal of the COOH-terminal lysine residue from each subunit of tissue MM creatine kinase by plasma carboxypeptidase N produces two additional isoforms that are readily separated, thereby permitting sensitive, early detection of acute myocardial infarction. Only two isoforms of MB creatine kinase have been detected in plasma leading to speculation that the COOH-terminal lysine on the B subunit is resistant to hydrolysis. To define the biochemical changes resulting in MB creatine kinase isoform conversion, we incubated highly purified MB creatine kinase from canine myocardium with plasma carboxypeptidase N. Quantitative anion-exchange chromatography of incubation mixtures and serial plasma samples from dogs subjected to coronary occlusion revealed a second, more acidic form evolved with time that was separated from the tissue isoform. Cyanogen bromide digestion of the two isoforms followed by amino acid sequencing of COOH-terminal peptides showed that MB creatine kinase undergoes removal of the COOH-terminal lysine residue from both M and B subunits. An intermediate form lacking lysine on the M subunit was delineated during incubations by the combined use of anion-exchange chromatography and conventional electrophoretic techniques. Thus, sequential cleavage of lysine from subunits of MB creatine kinase produces an intermediate isoform that has not been detected previously because of difficulties separating it from the tissue and fully converted isoforms.
Introduction
On activation of muscle, phosphocreatine, representing a storage and transport form of energy, is efficiently transphosphorylated by creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2) to yield ATP as the actual source of energy for contraction (1) . Creatine kinase occurs intracellularly as three cytoplasmic isoenzymes as well as a mitochondrial form (2) . Each cytoplasmic form is a dimer composed of M and/or B subunits expressed in a tissue-specific fashion. Thus, the MM homodimer is predominant in skeletal muscle and the BB homodimer is the major species in brain. The MB heterodimer has been found to comprise between 1% and 22% of the total creatine kinase activity present in human myocardium (3), but is absent from extracts of normal skeletal muscle or brain (4) . Accordingly, analysis of plasma MB creatine kinase activity has been used extensively for detection of acute myocardial infarction and quantification of the extent of myocardial injury in patients (5) .
Wevers et al. (6) were the first to report that plasma from patients with acute myocardial infarction contained three MM and two MB isoenzyme subforms with different isoelectric points (pI)' (hence isoforms) produced by modification of the primary translation product and separable by electrophoresis in agarose gels. We and others have shown that modification of the MM isoenzyme is characterized by successive removal of the COOH-terminal lysine residue from each M subunit by plasma carboxypeptidase N (EC 3.4.12.7) (7) (8) (9) (10) . This results in sequential and unidirectional conversion of the tissue isoform MM-3 (pI = 7.80) to isoforms MM-2 (pI = 7.50) and MM-l (pI = 7.20).2 Analysis ofthe relative proportions ofMM isoforms in plasma permits very early diagnosis of myocardial infarction and of myocardial reperfusion in response to thrombolytic therapy at a time when plasma MB and total creatine kinase activities are still within the normal reference range (11) (12) (13) (14) .
A potential limitation of analysis of isoforms of MM creatine kinase for detection of myocardial infarction and reperfusion results from expression of the M subunit at high levels in skeletal muscle. Thus, plasma MM creatine kinase activity may increase in conditions other than myocardial infarction. Quantification of individual isoforms of MB creatine kinase could improve specificity for myocardial infarction. However, whereas MM isoform conversion has been well characterized, similar understanding of the nature of MB isoform conversion has been limited by technical difficulties with purification of the relatively nonabundant MB heart of each was perfused before excision with 0.9% NaCi to remove blood rich in albumin. Sections of the left ventricle and of the excised cerebral cortex were frozen at -20'C. The MM and MB isoenzymes were purified from myocardium and the BB isoenzyme purified from brain as described previously (15) , except the elution buffer used for anion-exchange chromatography (50 mM Tris-HCl) was adjusted to pH 7.0 to improve separation ofthe MB isoenzyme from albumin and the BB isoenzyme from cytoplasmic proteins. MM was purified further by chromatofocusing as described previously (16) . The pooled, dialyzed fractions containing BB activity showed a single protein band after electrophoresis on SDS polyacrylamide gels, and hence did not require additional purification. However, because MB contained several protein moieties as assessed by electrophoresis, it was purified further by an affinity chromatography procedure (protocol provided by Yvonne Maynard, Washington University, St. Louis) with the use of a monoclonal antibody specific for the MB isoenzyme (17 Determination ofenzyme activity and protein.
Creatine kinase activity was assayed spectrophotometrically at 37°C with a coupled enzyme system (19) , creatine kinase-SVR reagent (Behring Diagnostics), and a miniature centrifugal analyzer (Gemeni; Electro-Nucleonics Inc., Fairfield, NJ). MB activity was assayed by a monoclonal antibody method described previously (17) . Carboxypeptidase N activity was assayed spectrophotometrically as described previously (20) . Protein was assayed by the method of Lowry et al. (21) .
Determination ofpI. Isoelectric points of MB isoforms were determined with the PhastSystem and PhastGel (both Pharmacia Fine Chemicals) containing ampholytes in the pH range of4.0-6.5. Purified isoforms and standards (0.5 Mg) with known pI were prefocused at 2,000 V, 2.0 mA constant power for 5 min, and separated at 2,000 V, 5 .0 mA for 20 min at 150C.
Digestion with cyanogen bromide. Protein (12 nmol) was dissolved in 70% formic acid containing a 30-fold molar excess of cyanogen bromide (CNBr) and kept at room temperature overnight in the dark. Samples were dried by lyophilization and resuspended in 25% trifluoroacetic acid in preparation for HPLC.
HPLC. Peptides were separated by reverse-phase HPLC with a model 5020 system (Varian Associates, Inc., Palo Alto, CA) and a Bondapak C18 column (Waters Associates, Milford, MA). The column was equilibrated with 0.05% trifluoroacetic acid (vol/vol). The peptide mixture was eluted at room temperature with a flow rate of 1 ml/min by use of a linear gradient of acetonitrile (0.25%/min for 120 min, 0.50%/min for 40 min, and 2.0%/min for 25 min) containing 0.05% trifluoroacetic acid.
Amino acid analysis. Peptides were hydrolyzed with 6 N HCl in sealed, evacuated glass tubes at 1 10°C for 24 h. Amino acid analyses were performed on a Waters programmable gradient high-pressure liquid chromatograph with postcolumn detection of ortho-phthalaldehyde derivatives and continuous hypochlorite infusion for the quantification of proline (22) . The yield of individual amino acid residues is reported relative to that of alanine.
Sequencing procedures. Peptides were sequenced from the NH2 terminus with a model 470A (Applied Biosystems, Inc., Foster City, CA) gas-phase protein sequenator and program "02N Vac" as supplied by the manufacturer. Between 0.5 and 2.0 nmol of peptide was subjected to Edman degradation with 95% repetitive yield. The phenylthiohydantoin (PTH) derivatives recovered after each cycle were identified by quantitative reverse-phase HPLC with a model 1084-B HPLC system (Hewlett-Packard Co., Palo Alto, CA) and a Brownlee C18 (PTH) column (Applied Biosystems).
Preparation ofpotential intermediateforms ofMB. To prepare the form of MB with the M subunit COOH-terminal lysine cleaved and the B subunit lysine intact (M-lys B+lys), MM (purified from canine myocardium) was digested with carboxypeptidase B and repurified by chromatofocusing to demonstrate complete conversion to M-lys M-lys (MM-1, pI = 7.51). Carboxypeptidase activity was not evident in fractions containing the repurified MM-1. Equimolar amounts of MM-I and BB (purified from canine brain) were mixed. The mixture was made 4 M with guanidine HCl containing 10.7 mM sodium acetate at pH 7.0, incubated at 30°C for 9 min, and dialyzed against 50 mM Tris-HCl (pH 7.0) containing 10 mM 2-mercaptoethanol for 72 h at4°C.
To prepare the form of MB with the M subunit COOH-terminal lysine intact and the B subunit COOH-terminal lysine cleaved (M+lys B-lys), BB was digested with carboxypeptidase B and repurified by FPLC with the use ofthe Mono Q anion-exchange column. Repurified BB eluted from the column as a single peak at 260 mM NaCl was distinguishable from the tissue form of BB, which eluted at 240 mM NaCI (see Fig. 6 ). The fractions containing BB activity did not show carboxypeptidase activity. Equimolar amounts of MM-3 and the converted form of BB were mixed together, denatured, and dialyzed as described above.
Preparation ofplasma samplesfor analysis ofMB isoforms. Heparinized blood samples were obtained from normal dogs (n = 6), and serially from conscious dogs subjected to coronary artery occlusion (n = 9) by tightening of a previously implanted coronary ligature as described (14) . Samples were centrifuged at 1,600 g for 10 min (4°C), the plasma separated, and EGTA and 2-mercaptoethanol added (10 and 5 mM final concentrations, respectively) to inhibit plasma carboxypeptidase activity and prevent inactivation of creatine kinase activity. Between 3 and 30 ml of plasma was applied to the MB antibody-Sepharose column to separate MB from plasma proteins. After dialysis against 50 mM Tris-HCI, pH 7.0, containing 5 mM 2-mercaptoethanol, 50-100 mIU of MB activity in a volume of 500 ,l was applied to the FPLC system described above.
Results
Purification ofMB creatine kinase. MB was purified to homogeneity (Fig. 1, lane B) with a final specific activity of up to 1, 1 (Fig. 2) . However, both the tissue and the converted isoforms ofcanine MB showed identical mobility after electrophoresis in denaturing SDS-polyacrylamide gels (Fig. 1 with a Mono Q anion-exchange column is used. The lower limit of sensitivity of the FPLC system was 5 mIU of creatine kinase activity per isoform peak. The recovery ofactivity from samples applied to the column was > 85%. MB purified from canine myocardium (Fig. 3) eluted from the column as a single peak of activity at 0.16 M NaCl. Digestion of the myocardial isoform with plasma carboxypeptidase N in vitro resulted in the appearance of a single second peak of activity that eluted from the column at 0.18 M NaCl (Fig. 3) .
To assess the time course of conversion of MB in vivo, we measured the relative activities in plasma of the two profiles of MB separated by FPLC at selected time points after myocardial infarction in dogs (Fig. 4) . Before coronary occlusion, and in normal unoperated dogs, both peaks of MB activity were present. By 9 h after coronary artery occlusion, a clear increase in the peak eluting at 0.16 M NaCl was evident, consistent with release of MB from infarcted myocardium. By 20 h after coronary artery occlusion, a significant fraction of the tissue form was processed to the converted form, as reflected by an increase in the activity eluting at 0.18 M NaCl.
Isolation and characterization ofpeptides unique to MB creatine kinase isoforms. To determine the biochemical changes that characterize conversion of MB creatine kinase isoforms, we prepared CNBr digests of the tissue and fully converted isoforms and fractionated the digests by HPLC (Fig.   5 ). Peptide maps of the tissue and converted isoforms were identical except for two peptide peaks. Both peptides present in the map of the tissue isoform (Fig. 5 B , B+lys, M+lys) were replaced by more hydrophobic peptides in the map of the converted isoform (Fig. 5 A, B- (23, 24) . Analysis of the two peptides unique to the converted isoform (M-lys and B-lys) indicated the sequences correspond to residues 377-380 of M and 364-380 of B creatine kinase, respectively; the predicted COOH-terminal CNBr peptides ofthe M and B subunits lacking the COOH-terminal lysine residues. These results were confirmed by quantitative amino acid analyses (Table III) . Thus, modification of MB creatine kinase by carboxypeptidase N results from specific cleavage of the COOH-terminal lysine residues from both the M and B subunits. (Fig. 6) . However, the M-lys B+lys form eluted from the FPLC column at 0.16 M NaCl, co-eluting with the tissue isoform. The M+lys B-lys form eluted from the FPLC column at 0.18 M NaCl, co-eluting with the converted isoform. Thus, cleavage of the COOH-terminal lysine residue from the B subunit but not the M subunit changes the elution profile of the isoenzyme from the anionexchange column.
In contrast to the results obtained by FPLC, agarose electrophoresis separated both intermediate forms from the more cathodal tissue isoform (Fig. 2) . However, electrophoresis did not appear to resolve the intermediates from each other or clearly separate them from the more anodal converted isoform (Fig. 2) . Thus, cleavage of the COOH-terminal lysine residue from either the M or B subunit results in a change in migration of MB after electrophoresis in agarose gels.
To (Fig. 2) ; and similar to the migration of both intermediate forms (M+lys B-lys and M-lys B+lys). However, because cleavage of the COOH-terminal lysine from the B subunit was shown to result in elution from the anion-exchange column at 0.18 M NaCl (Fig. 6) , the intermediate form identified in the activity peak at 0.16 M NaCl is probably M-lys B+lys.
Discussion
Based on delineation of two subforms of MB creatine kinase by agarose electrophoresis after hybridization of MM subforms isolated from plasma and BB purified from brain, Wevers et al. (25) concluded and others have supported the hypothesis (26) that only the M subunit of MB is modified by plasma factors. However, this has not been proven by structural analysis. Recently, the amino acid sequence of both the M and B subunits of creatine kinase has been determined by cDNA cloning in a number of species. We and others have shown an extraordinary degree ofamino acid identity between the M and B subunits (81% for canine M and B), which includes the COOH-terminal region ofthe molecule (24) . In fact, all M and B subunits sequenced to date terminate with the same sequence, Pro-Ala-Gln-Lys, and should be susceptible to digestion by pancreatic carboxypeptidase B or plasma carboxypeptidase N, which favors substrates with a COOH-terminal lysine residue (27) . The results of this study show that complete digestion of MB and BB creatine kinase with either carboxypeptidase B or with physiologic levels of purified carboxypeptidase N (recently shown to be the only plasma factor responsible for creatine kinase isoform conversion in vivo) (8, 10) leads to the apparent production of a single, second isoform with increased mobility toward the anode after electro- 1640 Billadello et al. phoresis in agarose gels (Fig. 2) , but no change in molecular weight as determined by electrophoresis in denaturing SDSpolyacrylamide gels (Fig. 1) . Nevertheless, comparison of peptide maps obtained by fractionation of CNBr digests of the tissue and converted isoforms of MB and amino acid analysis of peptides unique to each showed that the COOH-terminal lysine residues were removed from both the M and B subunits of the converted isoform (Fig. 5 , Tables I-III) . Removal of COOH-terminal lysine residues was the only modification that characterized MB isoform conversion. Because both the M and B subunits were susceptible to digestion by carboxypeptidases, we hypothesized that MB creatine kinase undergoes se- 
The CNBr peptides contained in the peaks identified in Fig. 5 (Fig. 4) . Under baseline conditions, approximately one-half of the MB activity eluted at 0. 16 M NaCl (Fig. 4) . Because baseline activity of MB creatine kinase was too low to evaluate by electrophoresis, it is not clear whether the activity eluted from the anion-exchange column at 0. 16 M NaCl comprises tissue isoform, M-lys B+lys intermediate or both. However, judging from the high proportion of fully converted MB isoform in normal canine plasma (Fig.  4 ) and the relatively low baseline proportion of the MM isoform from tissue documented previously (11, 13) , it seems likely that the profile at 0.16 M NaCl represents primarily the M-lys B+lys intermediate. Previous studies of MB isoenzyme modifications have been hampered by the inability to obtain highly purified MB from myocardium (25) , by the insensitivity of assays for MB isoforms (28) and because MB is unstable at its isoelectric point leading to denaturation with loss ofactivity. MB purified by our procedure was homogeneous as assessed by SDS-polyacrylamide gel electrophoresis and had a specific activity among the highest reported to date. The high-resolution anion-exchange chromatography method developed has facilitated purification of sufficient quantities of individual isoforms of MB to determine the nature of their modification by carboxypeptidase N. Its high sensitivity has enabled character-ization of the time course of conversion of MB isoforms in dogs after myocardial infarction and provided insight to the isoform composition in plasma under physiologic conditions. Although the method does not separate the tissue isoform from the M-lys B+lys intermediate, it distinguishes these isoforms from the fully converted isoform and therefore will be useful to monitor MB isoform conversion in vivo. Implementation of methods for separation ofall isoforms ofMB creatine kinase will facilitate application of isoform analysis for early and specific detection of myocardial infarction and reperfusion.
